Pfizer Limited

NSE PFIZER.NS

Pfizer Limited Revenue Per Share for the year ending March 31, 2024: USD 5.75

Pfizer Limited Revenue Per Share is USD 5.75 for the year ending March 31, 2024, a -10.87% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.

Pfizer Limited Revenue Per Share for the year ending March 31, 2023 was USD 6.45, a -14.19% change year over year.
Pfizer Limited Revenue Per Share for the year ending March 31, 2022 was USD 7.51, a 12.47% change year over year.
Pfizer Limited Revenue Per Share for the year ending March 31, 2021 was USD 6.68, a 7.07% change year over year.
Pfizer Limited Revenue Per Share for the year ending March 31, 2020 was USD 6.24, a -4.68% change year over year.

Key data

Date	Revenue Per Share	Dividend Per Share	Free Cash Flow Per Share	Return on Assets (ROA)

NSE: PFIZER.NS

Pfizer Limited

CEO	Ms. Meenakshi Nevatia
IPO Date	July 1, 2002
Location	India
Headquarters	The Capital
Employees	1,721
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Pfizer Limited manufactures, markets, trades in, and exports pharmaceutical products in India and internationally. The company offers its products in various therapeutic areas, including neuro/central nervous system, hormones, cardiovascular, hemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastro intestinal, vaccines, respiratory, and vitamins/minerals/nutrients. It sells its products through a network of independent distributors primarily under various brand names. The company was incorporated in 1950 and is headquartered in Mumbai, India.

Key trends

Past 5 years